Additionally, a recent study showed that the protective effects of liraglutide may be associated with increased mTOR expression via activation of the AMPK and PI3K/Akt signaling pathways in rats with type 2 diabetes (Yang et al., 2018). This evidence concerns the gene MTOR and type 2 diabetes mellitus.